A PYMNTS Company

UK: Competition Commission accepts buyout argument in laser eye case

By  |  November 22, 2013

The UK’s Competition Commission announced late last week that it has approved of the proposed buyout of laser eye company Ultralase by competitor Optimax Clinics following the argument that Ultralase would have gone out of business were it not for the acquisition.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Optimax finalized its buyout in November 2012, which involved the acquisition of 23 laser eye treatment clinics and three consultation locations throughout the UK, according to reports.

    Following its merger review, the Commission found that Optimax was the only viable purchaser option for Ultralase and confirmed that Ultralase would not have survived without a buyout.

    The Office of Fair Trading first referred the case to the Commission last July.

    Full Content: 4-Traders

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.